A Novel Therapeutic To Cure Dry Eye Disease with Dr Jeffery Nau, CEO, Oyster Point Pharma, Inc.
Leveraging neuroscience to discover and develop novel therapies to treat ocular surface diseases
Leveraging neuroscience to discover and develop novel therapies to treat ocular surface diseases